NCT04016389View on ClinicalTrials.gov

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

NARecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 11, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Cervical Cancer
Interventions
DRUG

Cisplatin

Cisplatin is an antineoplastic agent that is commonly used for the treatment of cervical cancer.

DRUG

Carboplatin

Carboplatin is an antineoplastic agent that is commonly used for the treatment of cervical cancer.

DRUG

Paclitaxel

Paclitaxel is an antineoplastic agent that is commonly used in combination with cisplatin or carboplatin for the treatment of cervical cancer.

PROCEDURE

Trachelectomy

Surgery to remove the cervix but keep the uterus intact.

Trial Locations (4)

77030

TERMINATED

MD Anderson Cancer Centre, Houston

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

G1R 2J6

RECRUITING

L'Hôtel-Dieu de Québec, Québec

All Listed Sponsors
collaborator

Hotel Dieu Hospital

OTHER

collaborator

The Netherlands Cancer Institute

OTHER

lead

University Health Network, Toronto

OTHER